catalpol has been researched along with mocetinostat in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cang, XF; Fan, YT; Hu, GY; Hu, YL; Qiu, L; Wan, R; Wang, XP; Wu, DQ; Xiao, WQ; Xing, M; Yin, GJ; Yu, G | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
2 other study(ies) available for catalpol and mocetinostat
| Article | Year |
|---|---|
Catalpol ameliorates sodium taurocholate-induced acute pancreatitis in rats via inhibiting activation of nuclear factor kappa B.
Topics: Acinar Cells; Amylases; Animals; Interleukin-1beta; Interleukin-6; Iridoid Glucosides; Lipase; Male; NF-kappa B; Pancreatitis, Acute Necrotizing; Peroxidase; Rats; Rats, Sprague-Dawley; Taurocholic Acid; Tumor Necrosis Factor-alpha | 2014 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |